Plain-English translation of NCT06536439 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Kidney Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new 3D computer planning tool called DIPLANN that helps surgeons decide how to remove kidney tumors while preserving as much healthy kidney as possible. The tool creates detailed 3D models from your CT scan to show exactly which blood vessels need to be blocked during surgery. Half of participants will have their surgery planned and guided using this new tool plus standard imaging, while the other half will receive standard care alone.
Currently, surgeons sometimes have to remove an entire kidney when a tumor could potentially be treated by removing just the tumor—because it's hard to predict which blood vessels to block during surgery to keep bleeding under control while minimizing damage to healthy kidney tissue. This new tool aims to make partial kidney removal safer and more feasible by giving surgeons a clear 3D picture of your kidney's blood supply.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to either the standard surgery planning group or the group using the new 3D DIPLANN tool for planning. Both groups will undergo robot-assisted partial nephrectomy (minimally invasive surgery to remove just the tumor). The main difference is that one group's surgery will be planned and guided using the new 3D imaging tool in addition to standard imaging. Your surgical team will use whichever approach you're assigned to help decide the best way to block blood vessels during your procedure to protect your remaining kidney function.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Belgium